RaySearch Laboratories AB (publ)
RSLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $262,865 | $110,088 | $32,375 | -$58,673 |
| Dep. & Amort. | $299,378 | $286,154 | $297,000 | $250,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$25,255 | $61,386 | $42,115 | $52,550 |
| Other Non-Cash | -$51,758 | -$1,697 | -$14,713 | -$5,715 |
| Operating Cash Flow | $485,230 | $455,931 | $356,777 | $238,162 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,261 | -$24,295 | -$231,501 | -$255,222 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$204,282 | -$185,035 | -$187,986 | $17,591 |
| Investing Cash Flow | -$217,543 | -$209,330 | -$231,501 | -$237,631 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$91,212 | -$56,350 | -$21,268 | -$28,382 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$68,566 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$56,350 | -$57,224 | -$43,852 |
| Financing Cash Flow | -$159,778 | -$56,350 | -$78,492 | -$72,234 |
| Forex Effect | $11,150 | -$6,838 | $10,949 | $5,492 |
| Net Chg. in Cash | $119,059 | $183,413 | $57,733 | -$66,211 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $343,681 | $160,268 | $102,535 | $168,746 |
| End Cash | $462,740 | $343,681 | $160,268 | $102,535 |
| Free Cash Flow | $267,687 | $246,601 | $125,276 | -$17,060 |